Footwear Difference in Sports Use in Runners With Functional Equinus

April 15, 2025 updated by: JORGE VELAZQUEZ SAORNIL, Universidad Católica de Ávila

Footwear Difference in Sports Use in Runners With Functional Equinus: Observational Study

Observational study on Nimbus shoes for daily training with 8mm drop and designed for heavier than normal weight. Shoe weight is 300g with highly structured buttress and upper with internal heat-sealed midfoot for greater lateral stability. This is a Novablast shoe with a mixed profile for training and competition with 8mm drp and higher midfoot compression range with less lateral containment.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Spain
      • Salamanca, Spain
        • Recruiting
        • Universidad Pontificia de Salamanca
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

regular runners with functional standing equine

Description

Inclusion Criteria:

  • patients with functional equine
  • regular runners

Exclusion Criteria:

  • patients with severe heterometry (more than 1 cm).
  • Recent lower limb interventions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
300 mg Nimbus shoe
Other: 250 mg Nimbus shoe
lightweight shoe

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
functional equine
Time Frame: 5 weeks
footprints measurement with camera and digital goniometer (measured in degrees).
5 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
algometry
Time Frame: 5 weeks
pressure pain threshold measured with digital algometer (measured in Newtons).
5 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Universidad Católica de Ávila

Investigators

  • Principal Investigator: Jorge SAORNIL, PhD., Universidad Pontificia de Salamanca

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 31, 2025

Primary Completion (Estimated)

July 1, 2025

Study Completion (Estimated)

December 30, 2025

Study Registration Dates

First Submitted

March 31, 2025

First Submitted That Met QC Criteria

April 15, 2025

First Posted (Actual)

April 16, 2025

Study Record Updates

Last Update Posted (Actual)

April 16, 2025

Last Update Submitted That Met QC Criteria

April 15, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 13/12/2024

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sport Injury

Clinical Trials on 250 mg Nimbus shoe

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Arab Emirates

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe